Proposed Data Collection Submitted for Public Comment and Recommendations, 46678-46680 [2016-16874]
Download as PDF
46678
Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
US Zika Pregnancy Registry—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In May 2015, the World Health
Organization reported the first local
transmission of Zika virus in the
Western Hemisphere, with
autochthonous cases identified in
Brazil. As of March 16, 2016, local
transmission has been identified in at
least 32 countries or territories in the
Americas. Further spread to other
countries in the region is likely. Local
vectorborne transmission of Zika virus
has not been documented in the 50 U.S.
states or the District of Columbia, but
has occurred in U.S. territories,
including in Puerto Rico, the U.S. Virgin
Islands, and American Samoa. However,
Zika virus infections have been reported
in travelers returning to the United
States from areas with active Zika virus
transmission. Zika virus infection also
has occurred through sexual
transmission, which may pose an
additional risk to non-travelling
pregnant women whose partners may
have traveled to areas at high risk for
Zika virus acquisition. With the ongoing
outbreak in the Americas, the number of
Zika virus disease cases among travelers
returning to the United States likely will
increase, and sexual transmission from
male travelers to their sex partners in
the United States will likely continue to
occur. In addition, mosquito-borne local
transmission may occur in states where
Aedes species mosquitoes are present.
In some Brazilian states where Zika
virus transmission has occurred, there
has been an increase in cases of infants
born with microcephaly. Zika virus
infections have been confirmed in
several infants with microcephaly and
in fetal losses in women infected during
pregnancy. In addition to microcephaly,
a range of other problems have been
detected among fetuses and infants
infected with Zika virus before birth,
such as absent or poorly developed
brain structures, defects of the eye,
hearing deficits, and impaired growth.
The Ministry of Health in Brazil, with
support from the Pan American Health
Organization (PAHO), the U.S. Centers
for Disease Control and Prevention
(CDC), and other partners, is
investigating the association between
Zika virus infection and microcephaly,
as well as other adverse pregnancy and
infant outcomes.
As part of the public health response
to the Zika virus disease outbreak, CDC
will conduct supplemental surveillance
of antenatal diagnostic testing and
clinical outcomes among pregnant
women with laboratory evidence of Zika
virus or unspecified flavivirus infection
and their infants through the U.S. Zika
Pregnancy Registry. It is anticipated that
the Registry will provide critical
information to direct CDC clinical
recommendations and public health
guidance and messages.
The objective of this Registry is to
monitor the frequency and types of
pregnancy and infant outcomes
following Zika virus infection during
pregnancy, so as to inform ongoing
response efforts for this Zika virus
disease outbreak, including
recommendations for clinical care,
planning for services for pregnant
women and infants affected by Zika
virus, and improved prevention of Zika
virus infections during pregnancy.
There are no costs to the respondents
other than their time. The total
estimated annual burden hours are
2,167.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Type of respondents
Form name
State, Territorial and Local Health Departments.
Maternal Health History Form ........................
100
10
30/60
Supplemental Imaging Form ..........................
Laboratory Results Form ...............................
Assessment at Delivery Form ........................
Infant Health Follow-Up Form ........................
100
100
100
100
10
10
10
30
10/60
15/60
30/60
15/60
Clinicians and Other Providers .......................
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2016–16872 Filed 7–15–16; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2016–0064; 60 Day–16–
0969]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
SUMMARY:
VerDate Sep<11>2014
17:52 Jul 15, 2016
Jkt 238001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on ‘‘Monitoring Changes in
Attitudes and Practices among Family
Planning Providers and Clinics,’’ a
survey to assess dissemination and use
of guidance documents about the use of
contraceptives and the delivery of
quality family planning services.
Written comments must be
received on or before September 16,
2016.
DATES:
E:\FR\FM\18JYN1.SGM
18JYN1
Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices
You may submit comments,
identified by Docket No. CDC–2016–
0064 by any of the following methods:
Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
ADDRESSES:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
VerDate Sep<11>2014
17:52 Jul 15, 2016
Jkt 238001
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Monitoring Changes in Attitudes and
Practices among Family Planning
Providers and Clinics (OMB No. 0920–
0969, exp. 5/31/2014)—Reinstatement
with Change—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Reproductive Health
(DRH) at the Centers for Disease Control
and Prevention (CDC) develops and
disseminates guidance to improve the
use of contraceptives and the delivery of
quality family planning services. The
U.S. Medical Eligibility Criteria for
Contraceptive Use (US MEC), the first
national guidance on family planning
containing evidence-based
recommendations for the safe use of
contraceptive methods for women and
men with specific characteristics and
medical conditions, was published by
the CDC in June 2010. The US Selected
Practice Recommendations for
Contraceptive Use (US SPR), which
provides guidance on how to use
contraceptive methods safely and
effectively once they are deemed to be
medically appropriate, was published
by the CDC in June 2013. Providing
Quality Family Planning Services (QFP),
which provides evidence-informed
recommendations to improve client care
and service delivery infrastructure to
support the provision of quality family
planning services to women and men of
reproductive age in the United States,
was published by CDC and the Office of
Population Affairs (OPA) in April 2014.
The US MEC, US SPR, and QFP have
been widely disseminated to health care
providers and other constituents via
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
46679
professional organizations, federal
program grantees, scientific and
programmatic meetings, scientific
manuscripts, online resources, and
other avenues.
In 2009–2010, CDC collected baseline
information related to diffusion and use
of the US MEC (OMB No. 0920–0008).
In 2013–2014, CDC collected follow-up
information related to the US MEC and
baseline information related to the US
SPR and QFP (OMB No. 0920–0969).
These information collections provided
useful knowledge about differences in
attitudes and practices of family
planning providers based on varying
levels of key demographic
characteristics (e.g., years since
completion of formal health care
training), and identification of attitudes
not consistent with current scientific
evidence (e.g., misconceptions that
intrauterine devices are not safe for
adolescents or nulliparous women).
CDC used findings to develop
educational materials and opportunities
for health care providers.
In 2017, in collaboration with the
HHS Office of Population Affairs (OPA),
CDC plans to request a reinstatement of
OMB No. 0920–0969, ‘‘Monitoring
Changes in Attitudes and Practices
among Family Planning Providers and
Clinics.’’ The information collection
will allow CDC and OPA to assess
changes in attitudes and practices
among family planning providers and
clinics after the release of these three
national guidance documents, and to
identify persisting misconceptions and/
or gaps in clinic-level practices (e.g.,
low provision of preconception health
services) that may warrant continued
and more tailored dissemination and
educational activities. Specifically, the
survey will allow CDC and OPA to
improve family planning-related public
health practice by (1) understanding the
current use of contraception guidance in
practice and valued sources of
contraceptive information, including
awareness and use of the US MEC, US
SPR and QFP; (2) describing current
attitudes and practices among family
planning providers and clinics related
to recommendations included in the US
MEC, US SPR, and QFP and assessing
changes from baseline; and (3)
identifying targeted training needs in
use of guidance and family planning
service delivery (e.g., provider tools,
continuing education modules).
In 2017–2018, CDC plans to
administer a follow-up survey to a
sample of 10,000 private- and publicsector family planning providers and
clinic administrators in the United
States. The design, methodology, and
analytic approach are based on methods
E:\FR\FM\18JYN1.SGM
18JYN1
46680
Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices
previously approved for the 2013–2014
survey. Minor changes to survey content
will be made to eliminate unnecessary
questions, add new questions of
interest, and improve formatting,
usability, and data quality. As in 2013–
2014, different versions of the survey
instrument will be administered to
providers and clinic administrators. The
estimated burden per response for
providers is 15 minutes and has not
changed since the previous OMB
approval. The estimated burden per
response for administrators will be
reduced from 40 minutes to 25 minutes.
Private-sector physicians will be
randomly selected from sampling
frames with individual-level
information on physicians. To reach
public-sector providers and clinic
administrators, publicly funded clinics
will be randomly selected; one provider
and the clinic administrator will be
asked to complete surveys at sampled
clinics. Specifically, surveys will be
completed by: (a) 2,000 private-sector
office-based physicians (i.e., those
specializing in obstetrics/gynecology,
family medicine, and adolescent
medicine), sampled from the American
Medical Association Physician
Masterfile; (b) 2,000 providers from
Title X clinics, sampled from a database
of publicly funded family planning
clinics; (c) 2,000 providers from nonTitle X clinics, sampled from a database
of publicly funded family planning
clinics; (d) 2,000 clinic administrators
from Title X clinics, sampled from a
database of publicly funded family
planning clinics; and (e) 2,000 clinic
administrators from non-Title X clinics,
sampled from a database of publicly
funded family planning clinics.
Each sampled provider and clinic will
receive a mailed survey package. For
private-sector family planning
providers, each mailed survey package
will include a single survey to be
completed by the provider. For publicsector clinics, each mailed survey
package will include two surveys—one
to be completed by a randomly selected
family planning provider at the clinic,
and the second to be completed by the
clinic administrator. Each mailed survey
will be accompanied by a postage-paid
return envelope. Individuals will also be
given the option to complete the survey
online via a password protected webbased data collection system.
OMB approval is requested for one
year. Participation is voluntary and
there are no costs to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number
responses per
respondent
Average
burden per
response
(in hr)
Total burden
(in hr)
Type of respondents
Form name
Office-based physicians (private sector).
Title X clinic providers (public sector)
2017 Survey of Health Care Providers.
2017 Survey of Health Care Providers.
2017 Survey of Health Care Providers.
2017 Survey of Administrators of
Publicly-Funded Health Centers
that Provide Family Planning.
2017 Survey of Administrators of
Publicly-Funded Health Centers
that Provide Family Planning.
2,000
1
15/60
500
2,000
1
15/60
500
2,000
1
15/60
500
2,000
1
25/60
834
2,000
1
25/60
834
...........................................................
........................
........................
........................
3,168
Non-Title X publicly funded clinic
providers (public sector).
Title X clinic administrators (public
sector).
Non-Title X publicly funded clinic administrators (public sector).
Total ...........................................
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2016–16874 Filed 7–15–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2016–0063; 60Day–16–
16AVC]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
VerDate Sep<11>2014
17:52 Jul 15, 2016
Jkt 238001
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on ‘‘Generic Clearance for
CDC/ATSDR Formative Research and
Tool Development’’. This information
collection request is designed to allow
CDC to conduct formative research
information collection activities used to
inform aspects of surveillance,
communications, health promotion, and
research project development.
DATES: Written comments must be
received on or before September 16,
2016.
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
You may submit comments,
identified by Docket No. CDC–2016–
0063 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
ADDRESSES:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
E:\FR\FM\18JYN1.SGM
18JYN1
Agencies
[Federal Register Volume 81, Number 137 (Monday, July 18, 2016)]
[Notices]
[Pages 46678-46680]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16874]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2016-0064; 60 Day-16-0969]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on ``Monitoring
Changes in Attitudes and Practices among Family Planning Providers and
Clinics,'' a survey to assess dissemination and use of guidance
documents about the use of contraceptives and the delivery of quality
family planning services.
DATES: Written comments must be received on or before September 16,
2016.
[[Page 46679]]
ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0064 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Monitoring Changes in Attitudes and Practices among Family Planning
Providers and Clinics (OMB No. 0920-0969, exp. 5/31/2014)--
Reinstatement with Change--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Division of Reproductive Health (DRH) at the Centers for
Disease Control and Prevention (CDC) develops and disseminates guidance
to improve the use of contraceptives and the delivery of quality family
planning services. The U.S. Medical Eligibility Criteria for
Contraceptive Use (US MEC), the first national guidance on family
planning containing evidence-based recommendations for the safe use of
contraceptive methods for women and men with specific characteristics
and medical conditions, was published by the CDC in June 2010. The US
Selected Practice Recommendations for Contraceptive Use (US SPR), which
provides guidance on how to use contraceptive methods safely and
effectively once they are deemed to be medically appropriate, was
published by the CDC in June 2013. Providing Quality Family Planning
Services (QFP), which provides evidence-informed recommendations to
improve client care and service delivery infrastructure to support the
provision of quality family planning services to women and men of
reproductive age in the United States, was published by CDC and the
Office of Population Affairs (OPA) in April 2014. The US MEC, US SPR,
and QFP have been widely disseminated to health care providers and
other constituents via professional organizations, federal program
grantees, scientific and programmatic meetings, scientific manuscripts,
online resources, and other avenues.
In 2009-2010, CDC collected baseline information related to
diffusion and use of the US MEC (OMB No. 0920-0008). In 2013-2014, CDC
collected follow-up information related to the US MEC and baseline
information related to the US SPR and QFP (OMB No. 0920-0969). These
information collections provided useful knowledge about differences in
attitudes and practices of family planning providers based on varying
levels of key demographic characteristics (e.g., years since completion
of formal health care training), and identification of attitudes not
consistent with current scientific evidence (e.g., misconceptions that
intrauterine devices are not safe for adolescents or nulliparous
women). CDC used findings to develop educational materials and
opportunities for health care providers.
In 2017, in collaboration with the HHS Office of Population Affairs
(OPA), CDC plans to request a reinstatement of OMB No. 0920-0969,
``Monitoring Changes in Attitudes and Practices among Family Planning
Providers and Clinics.'' The information collection will allow CDC and
OPA to assess changes in attitudes and practices among family planning
providers and clinics after the release of these three national
guidance documents, and to identify persisting misconceptions and/or
gaps in clinic-level practices (e.g., low provision of preconception
health services) that may warrant continued and more tailored
dissemination and educational activities. Specifically, the survey will
allow CDC and OPA to improve family planning-related public health
practice by (1) understanding the current use of contraception guidance
in practice and valued sources of contraceptive information, including
awareness and use of the US MEC, US SPR and QFP; (2) describing current
attitudes and practices among family planning providers and clinics
related to recommendations included in the US MEC, US SPR, and QFP and
assessing changes from baseline; and (3) identifying targeted training
needs in use of guidance and family planning service delivery (e.g.,
provider tools, continuing education modules).
In 2017-2018, CDC plans to administer a follow-up survey to a
sample of 10,000 private- and public-sector family planning providers
and clinic administrators in the United States. The design,
methodology, and analytic approach are based on methods
[[Page 46680]]
previously approved for the 2013-2014 survey. Minor changes to survey
content will be made to eliminate unnecessary questions, add new
questions of interest, and improve formatting, usability, and data
quality. As in 2013-2014, different versions of the survey instrument
will be administered to providers and clinic administrators. The
estimated burden per response for providers is 15 minutes and has not
changed since the previous OMB approval. The estimated burden per
response for administrators will be reduced from 40 minutes to 25
minutes.
Private-sector physicians will be randomly selected from sampling
frames with individual-level information on physicians. To reach
public-sector providers and clinic administrators, publicly funded
clinics will be randomly selected; one provider and the clinic
administrator will be asked to complete surveys at sampled clinics.
Specifically, surveys will be completed by: (a) 2,000 private-sector
office-based physicians (i.e., those specializing in obstetrics/
gynecology, family medicine, and adolescent medicine), sampled from the
American Medical Association Physician Masterfile; (b) 2,000 providers
from Title X clinics, sampled from a database of publicly funded family
planning clinics; (c) 2,000 providers from non-Title X clinics, sampled
from a database of publicly funded family planning clinics; (d) 2,000
clinic administrators from Title X clinics, sampled from a database of
publicly funded family planning clinics; and (e) 2,000 clinic
administrators from non-Title X clinics, sampled from a database of
publicly funded family planning clinics.
Each sampled provider and clinic will receive a mailed survey
package. For private-sector family planning providers, each mailed
survey package will include a single survey to be completed by the
provider. For public-sector clinics, each mailed survey package will
include two surveys--one to be completed by a randomly selected family
planning provider at the clinic, and the second to be completed by the
clinic administrator. Each mailed survey will be accompanied by a
postage-paid return envelope. Individuals will also be given the option
to complete the survey online via a password protected web-based data
collection system.
OMB approval is requested for one year. Participation is voluntary
and there are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondents Form name respondents responses per response (in (in hr)
respondent hr)
----------------------------------------------------------------------------------------------------------------
Office-based physicians 2017 Survey of 2,000 1 15/60 500
(private sector). Health Care
Providers.
Title X clinic providers 2017 Survey of 2,000 1 15/60 500
(public sector). Health Care
Providers.
Non-Title X publicly funded 2017 Survey of 2,000 1 15/60 500
clinic providers (public Health Care
sector). Providers.
Title X clinic administrators 2017 Survey of 2,000 1 25/60 834
(public sector). Administrators
of Publicly-
Funded Health
Centers that
Provide Family
Planning.
Non-Title X publicly funded 2017 Survey of 2,000 1 25/60 834
clinic administrators (public Administrators
sector). of Publicly-
Funded Health
Centers that
Provide Family
Planning.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,168
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-16874 Filed 7-15-16; 8:45 am]
BILLING CODE 4163-18-P